Group One Trading’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.06K Sell
1,284
-6,767
-84% -$62.8K ﹤0.01% 6480
2025
Q4
$98.7K Sell
8,051
-1,623
-17% -$26.5K ﹤0.01% 5024
2025
Q3
$198K Sell
9,674
-8,328
-46% -$132K ﹤0.01% 4672
2025
Q2
$243K Buy
+18,002
New +$197K ﹤0.01% 4146
2025
Q1
Sell
-6,244
Closed -$38.2K 8154
2024
Q4
$30.3K Sell
6,244
-2,482
-28% -$13.9K ﹤0.01% 5429
2024
Q3
$67.4K Buy
8,726
+6,565
+304% +$58.4K ﹤0.01% 4450
2024
Q2
$21.6K Sell
2,161
-9,057
-81% -$99.5K ﹤0.01% 5169
2024
Q1
$136K Buy
+11,218
New +$163K ﹤0.01% 3875
2022
Q2
Sell
-89,933
Closed -$2.66M 8312
2022
Q1
$3.39M Buy
+89,933
New +$3.98M ﹤0.01% 1873
2020
Q2
Sell
-3,657
Closed -$39.8K 6066
2020
Q1
$33K Sell
3,657
-6,740
-65% -$63.9K ﹤0.01% 3972
2019
Q4
$107K Buy
+10,397
New +$118K ﹤0.01% 3594

Other funds holding OPRX

Group One Trading's OPRX Position: Q1 2026 in Review

Group One Trading reduced its OptimizeRx (OPRX) stake by 84% in Q1 2026, selling an estimated $62.8K and leaving 1,284 shares worth $8.06K. The position accounts for ﹤0.01% of the portfolio, ranked #6480.

Group One Trading first reported a position in OPRX in Q4 2019 and has held it in 11 quarters since. The position peaked at $3.39M in Q1 2022. 127 funds tracked by Wall St. Rank hold OPRX as of Q1 2026.

  • Group One Trading held 1,284 shares of OptimizeRx worth $8.06K as of Q1 2026.
  • Group One Trading sold 6,767 OptimizeRx shares in Q1 2026, an estimated $62.8K.
  • OptimizeRx made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #6480 holding.
  • Group One Trading first reported a position in OptimizeRx in Q4 2019 and has held it in 11 quarters since.
  • Group One Trading's OptimizeRx position peaked at $3.39M in Q1 2022.
  • 127 funds tracked by Wall St. Rank held OptimizeRx as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.